45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
12,221
Insurances with rates
10
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| RX-213069 | AFAMITRESGENE AUTOLEUCEL 2.68X 10EXP9 TO 10X 10EXP9 CELL IV SUSPENSION | $10,977,700 | — | — | — | 11 |
| RX-211623 | LIFILEUCEL 7.5 X 10EXP9 TO 72 X 10EXP9 CELL INTRAVENOUS SUSPENSION | $8,486,200 | — | — | — | 11 |
| RX-204856 | CILTACABTAGENE AUTOLEUCEL 0.5 X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION | $8,385,188 | — | — | — | 18 |
| RX-201692 | LISOCABTAGENE MARALEUCEL 1.5 X 10EXP6 TO 70 X 10EXP6 CELL/ML IV SUSP | $8,023,391 | — | — | — | 18 |
| RX-202106 | IDECABTAGENE VICLEUCEL 300 X 10EXP6 TO 510 X 10EXP6 CELL IV SUSPENSION | $7,977,518 | — | — | — | 18 |
| RX-208670 | OMIDUBICEL-ONLV INTRAVENOUS SUSPENSION | $7,732,257 | — | — | — | 11 |
| RX-2107307868 | OMIDUBICEL-ONLV CULTURED FRACTION (CF) IV SUSPENSION (1OF2) | $7,732,257 | — | — | — | 11 |
| RX-2107307869 | OMIDUBICEL-ONLV NON-CULTURED FRACTION (NF) IV SUSPENSION (2OF2) | $7,732,257 | — | — | — | 11 |
| RX-189051 | AXICABTAGENE CILOLEUCEL INTRAVENOUS SUSPENSION | $7,050,120 | — | — | — | 18 |
| RX-188776 | TISAGENLECLEUCEL 0.2 X10EXP6 TO 2.5X10EXP8 CELL INTRAVENOUS SUSPENSION | $6,899,810 | — | — | — | 18 |
| RX-190598 | TISAGENLECLEUCEL 0.6 X 10EXP8 TO 6 X10EXP8 CELL INTRAVENOUS SUSPENSION | $6,899,810 | — | — | — | 18 |
| RX-199955 | BREXUCABTAGENE AUTOLEUCEL 2X 10EXP6 TO 2X 10EXP8 CELL IV SUSPENSION | $6,468,000 | — | — | — | 18 |
| RX-4082206 | INV - OBECABTAGENE AUTOLEUCEL INTRAVENOUS SYRINGE 10 X 10EXP6 CELL (IRB# EA25-1017) | $3,963,750 | — | — | — | 11 |
| RX-4082207 | INV - OBECABTAGENE AUTOLEUCEL INTRAVENOUS SUSPENSION 300 X 10EXP6 CELL (IRB# EA25-1017) | $3,963,750 | — | — | — | 11 |
| RX-205700 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $1,626,284 | — | — | — | 16 |
| RX-155216 | SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION | $853,025 | — | — | — | 18 |
| RX-204948 | LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1,000 MBQ/ML) IV SOLN | $781,795 | — | — | — | 14 |
| RX-189868 | LUTETIUM LU 177 DOTATATE 10 MCI/ML (370 MBQ/ML) INTRAVENOUS SOLUTION | $685,391 | — | — | — | 14 |
| RX-164248 | GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION | $589,095 | — | — | — | 14 |
| RX-159835 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $493,521 | — | — | — | 16 |
| RX-212089 | NOGAPENDEKIN ALFA INBAKICEPT-PMLN 400 MCG/0.4 ML INTRAVESICAL SOLUTION | $487,813 | — | — | — | 16 |
| RX-211245 | EMICIZUMAB-KXWH 300 MG/2 ML (150 MG/ML) SUBCUTANEOUS SOLUTION | $438,540 | — | — | — | 16 |
| RX-158898 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $418,906 | — | — | — | 16 |
| RX-186154 | NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $387,104 | — | — | — | 14 |
| RX-202485 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $385,914 | — | — | — | 16 |
| RX-206646 | SPESOLIMAB-SBZO 60 MG/ML INTRAVENOUS SOLUTION | $380,212 | — | — | — | 16 |
| RX-195861 | TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION | $347,864 | — | — | — | 32 |
| RX-218052 | PEMBROLIZUMAB 790 MG-BERAHYALURONID-PMPH 9,600 UNIT/4.8 ML SUBCUT SOLN | $327,880 | — | — | — | 11 |
| RX-197475 | CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION | $327,025 | — | — | — | 16 |
| RX-200763 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $326,357 | — | — | — | 32 |
| RX-185941 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $325,880 | — | — | — | 16 |
| RX-176742 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION | $319,080 | — | — | — | 16 |
| RX-199094 | MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT | $316,493 | — | — | — | 16 |
| RX-186942 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $281,255 | — | — | — | 16 |
| RX-14472 | PORFIMER 75 MG INTRAVENOUS SOLUTION | $278,340 | — | — | — | 14 |
| RX-12519 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $277,162 | — | — | — | 16 |
| RX-155972 | COAGULATION FACTOR VIIA RECOMB 8 MG (8,000 MCG) INTRAVENOUS SOLUTION | $258,961 | — | — | — | 16 |
| RX-2104500618 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $253,600 | — | — | — | 16 |
| 42210799 | HC STEREO RAD,SGL TX,(IMAGE-GUID) | $248,801 | — | — | — | 13 |
| RX-198407 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $245,527 | — | — | — | 16 |
| 38301206 | HC TMR LASER | $238,966 | — | — | — | 15 |
| RX-208999 | EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION | $224,562 | — | — | — | 16 |
| RX-189356 | EMICIZUMAB-KXWH 150 MG/ML SUBCUTANEOUS SOLUTION | $219,270 | — | — | — | 16 |
| RX-209571 | NADOFARAGENE FIRADENOVEC-VNCG 3X10EXP11 VP/ML INTRAVESICAL SUSPENSION | $218,017 | — | — | — | 16 |
| RX-204937 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $210,141 | — | — | — | 16 |
| RX-153810 | PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION | $209,000 | — | — | — | 16 |
| RX-212514 | TARLATAMAB-DLLE 10 MG INTRAVENOUS SOLUTION | $204,391 | — | — | — | 16 |
| RX-208402 | RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION | $200,889 | — | — | — | 16 |
| RX-155530 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $198,588 | — | — | — | 16 |
| RX-213494 | GUSELKUMAB 200 MG/20 ML (10 MG/ML) INTRAVENOUS SOLUTION | $198,384 | — | — | — | 16 |
Showing top 50 of 12,221 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.